GenMark Diagnostics, Inc. GNMK
— —
Day range unavailable
52-week range unavailable
News
gurufocus.com GenomeWeb Index Drops 3% for 2nd Consecutive Month Meridian Bioscience Inc. (NASDAQ:VIVO) edged out GenMark Diagnostics Inc. (NASDAQ:GNMK) as the top gainer in the March GenomeWeb Index with a 25% boost in its share price compared to GenMark's 22.5%…
prnewswire.com INVESTIGATION ALERT: Halper Sadeh LLP Investigates LMNX, NUAN, CADE, GNMK; Shareholders are Encouraged to Contact the Firm NEW YORK, April 13, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Luminex Corporation (NASDAQ: LMNX) concerning…
gurufocus.com Italian Diagnostic Developer Calls Luminex a 'Perfect Fit' Investors reacted favorably over the announcement that Saluggia, Italy-based DiaSorin SpA (MIL:DIA) is paying $1.8 billion to purchase Austin, Texas-based Luminex Corp. (NASDAQ:LMNX), a developer of…
benzinga.com Stocks That Hit 52-Week Highs On Friday Before 10 a.m. ET Friday, 108 stocks made new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Thursday Thursday morning saw 23 companies set new 52-week highs.
zacks.com GenMark Diagnostics (GNMK) Enters Overbought Territory GenMark Diagnostics (GNMK) has moved higher as of late, but there could definitely be trouble on the horizon for this company
prnewswire.com SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of GenMark Diagnostics, Inc. - GNMK NEW YORK, March 19, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities…
prnewswire.com GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. NEW YORK and SAN DIEGO, March 16, 2021 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating GenMark Diagnostics ("GenMark") (NASDAQ: GNMK) regarding possible…
benzinga.com 3 Cancer Diagnostic Stocks To Watch Following Roche's GenMark Buy Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a $1.8 billion deal on Monday, the same day Veracyte Inc (NASDAQ: VCYT) announced it completed the acquisition of…
zacks.com GenMark Diagnostics (GNMK) Soars 29.6%: Is Further Upside Left in the Stock? GenMark Diagnostics (GNMK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price…
fool.com Why GenMark Stock Soared Today A healthcare titan is acquiring the diagnostic-test maker for a hefty premium.
globenewswire.com SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GenMark Diagnostics, Inc. Buyout WILMINGTON, Del., March 15, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating GenMark Diagnostics, Inc. (“GenMark”) (NASDAQ GM: GNMK) regarding possible breaches of…
schaeffersresearch.com GNMK Grabs Fresh Highs on Billion-Dollar Buyout Buzz GenMark Diagnostics Inc (NASDAQ:GNMK) stock is surging today, up 29.1% to trade at $23.88 at last check, after news of its buyout.
prnewswire.com SHAREHOLDER ALERT: WeissLaw LLP Investigates GenMark Diagnostics, Inc. NEW YORK, March 15, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GenMark Diagnostics, Inc.…
globenewswire.com GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. NEW YORK and SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating GenMark Diagnostics (“GenMark”) (NASDAQ: GNMK) regarding…
businesswire.com GenMark Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of GenMark Diagnostics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – GNMK NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of GenMark Diagnostics, Inc. (NASDAQ: GNMK) to Roche is fair to GenMark shareholders.…
benzinga.com Stocks That Hit 52-Week Highs On Monday On Monday morning, 415 companies achieved new highs for the year.
barrons.com GenMark Shares Surge After Roche Announces $1.8 Billion Deal for Molecular Test Maker Shares of U.S.-based GenMark were shooting higher on Monday, after Swiss pharmaceutical group Roche said it will buy the California-based company.
zacks.com Roche (RHHBY) Inks Deal to Acquire GenMark Diagnostics for $1.8B Roche (RHHBY) signs an agreement to acquire GenMark Diagnostics to test a broad range of pathogens using one patient sample. The deal is valued at around $1.8 billion on a fully diluted basis.
pulse2.com GNMK Stock Price Increases Over 25% Pre-Market: Why It Happened The stock price of GenMark Diagnostics, Inc (NASDAQ: GNMK) is trading at over 25% pre-market. This is why it happened.
invezz.com Roche to buy U.S. based GenMark Diagnostics for £1.29 billion Roche Holding AG (SWX: RO) said on Monday that it will buy GenMark Diagnostics (NASDAQ: GNMK) for £1.29 billion. The all-cash deal translates to £17.25 per share.
benzinga.com Roche Boosts Diagnostics Portfolio With $1.8B Bet On COVID-19 Test Manufacturer GenMark Swiss drug giant Roche Holding AG (OTC: RHHBY) announced a big-ticket acquisition that would boost its presence in the diagnostics market, setting the tempo for a merger Monday. What Happened: Roche…
reuters.com Roche agrees to buy GenMark Diagnostics in $1.8 billion deal Roche will buy GenMark Diagnostics, a U.S.-based maker of molecular diagnostic tests in a $1.8 billion deal, the Swiss pharmaceuticals manufacturer said on Monday.
benzinga.com Earnings Scheduled For February 25, 2021 Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings at $0.23 per share on revenue of $4.78 billion.
benzinga.com Stocks That Hit 52-Week Highs On Thursday Before 10 a.m. ET on Thursday, 394 companies hit new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Wednesday Wednesday's morning session saw 274 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday On Wednesday, 140 companies set new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Monday On Monday, 107 stocks hit new 52-week highs.
benzinga.com 65 Biggest Movers From Yesterday Gainers Urban One, Inc. (NASDAQ: UONE) shares jumped 255.4% to close at $6.54 on Monday after surging around 22% on Friday.- benzinga.com Stocks That Hit 52-Week Highs On Tuesday On Tuesday, 50 stocks hit new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday On Tuesday, the following companies hit new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Friday During Friday's morning session, 29 stocks hit new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Thursday During Thursday's morning trading, these companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday On Wednesday morning, 30 companies achieved new highs for the year.
- benzinga.com 31 Stocks Moving in Friday's Pre-Market Session
- benzinga.com 144 Biggest Movers From Friday
- benzinga.com 85 Biggest Movers From Yesterday
benzinga.com 50 Stocks Moving In Tuesday's Mid-Day Session - benzinga.com Stocks That Hit 52-Week Lows On Thursday
- benzinga.com Stocks That Hit 52-Week Lows On Thursday
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday
benzinga.com Benzinga's Top Upgrades, Downgrades For February 11, 2020 - benzinga.com Benzinga's Top Upgrades, Downgrades For December 11, 2019